Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Pii announced the FDA has issued their EIRs for both FEI registration numbers (1000513101/3006503102), covering Pii's facilities in Hunt Valley and Cockeysville, MD.
read more
GHO Capital has acquired a majority stake in Sterling Pharma Solutions, a specialist in complex and difficult to manufacture APIs.
read more
Wednesday, March 13, 2019
SGS welcomed the preliminary data from a controlled human infection trial with FluGen’s investigational M2SR vaccine.
read more
Wednesday, March 13, 2019
Particle Sciences has announced the appointment of Karen Bossert as vice president of operations as part of its ongoing strategy to grow and enhance its manufacturing capabilities.
read more
Fujifilm will acquire the shares of Biogen’s subsidiary, which holds Biogen’s biologics manufacturing operations in Hillerød, Denmark.
read more
ReForm Biologics announced a collaboration with Astellas Pharma to reduce the viscosity of an Astellas clinical-stage biological pipeline program.
read more
Cellectis has entered into a lease agreement to build an 82,000 square foot commercial-scale manufacturing facility named IMPACT in Raleigh, North Carolina.
read more
Wednesday, March 06, 2019
STA Pharmaceutical, a subsidiary of WuXi AppTec, and Ark Biosciences announced a strategic partnership for CMC development and manufacturing.
read more
Recipharm has achieved the new ISO 45001 certification at its Wasserburg facility in Germany.
read more
AGC has announced the completion of its acquisition of Spain's synthetic pharmaceutical active ingredient manufacturer, Malgrat Pharma Chemicals, S.L.U. (MPC).
read more
Danaher has entered into a definitive agreement with General Electric Company (GE) to acquire the Biopharma business of GE Life Sciences (GE Biopharma) for a cash purchase price of approximately $21.4 billion.
read more
MedPharm has announced two new appointments to its Board to support plans to grow its commercial manufacturing services.
read more
Thursday, February 28, 2019
One of today’s most important tools for modernizing the pharmaceutical industry is a process known as continuous manufacturing (CM).
read more
Monday, February 25, 2019
Nemus Bioscience has signed an agreement with Pharmaceuticals International Inc. (Pii), a CDMO to develop a sterile eye drop dosage formulation of NB1111 for human dosing.
read more
Monday, February 25, 2019
WuXi Biologics announced that the EMA has completed the PAI of the company's cGMP Drug Substance and Drug Product manufacturing facilities for the production of Trogarzo with no critical findings.
read more